Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Bhorade (Chicago, IL, United States of America), E. Morgenthien (South San Francisco, CA, United States of America), J. Castle (South San Francisco, CA, United States of America), S. Limb (South San Francisco, CA, United States of America), J. Mehta (Chicago, IL, United States of America). Changes in neutrophil-lymphocyte and platelet-lymphocyte ratios and clinical outcomes in idiopathic pulmonary fibrosis. 4805

Member's Comments

No comment yet.

Related content which might interest you: Stability of blood eosinophilia and neutrophil-to-lymphocyte ratio in COPD Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Evaluation of FVC/DLCO ratio as a predictor for pulmonary hypertension in patients with interstitial lung diseases Source: International Congress 2017 – ILDs: clinical problems Year: 2017 Defining the role of neutrophil-to-lymphocyte ratio in COPD patients Source: Virtual Congress 2020 – Prognosis and integrated management of COPD Year: 2020 Systemic inflammation in exacerbated patients with chronic obstructive pulmonary disease (COPD): the role of alterations in leptin/ghrelin ratio and/or leptin/adiponectin ratio Source: Annual Congress 2007 - Biomarkers and assessment of COPD Year: 2007 Selected blood parameters of inflammation (circulating immune complexes, CIC, C-reactive protein, CRP, neutrophil/ lymphocyte ratio and platelet/lymphocyte ratio) in patients with chronic obstructive pulmonary disease (COPD) Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD Year: 2020 Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis Source: Annual Congress 2004 - Fibrosing lung diseases Year: 2004 Clinical course of idiopathic pulmonary fibrosis (IPF): Prediction and outcome Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011 Comparison of clinical characteristics and prognostic factors between combined pulmonary fibrosis and emphysema/UIP versus non-UIP Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Correlation between physical activity and prognostic markers in patients with idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 Prognostic evaluation in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011 A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis Source: Eur Respir J 2010; 36: 1067-1072 Year: 2010 Effect of baseline composite physiologic index on benefit of nintedanib in IPF Source: International Congress 2016 – IPF treatment I Year: 2016 Importance of serial changes in biomarkers in idiopathic pulmonary fibrosis Source: ERJ Open Res, 3 (3) 00019-2016; 10.1183/23120541.00019-2016 Year: 2017 Evaluation of neutrophil lymphocyte ratio and C-reactive protein values in the treatment of acute chronic obstructive pulmonary disease exacerbation according to endotype Source: Virtual Congress 2020 – Monitoring of patients with COPD Year: 2020 Difference of the clinical characteristics and outcome between interstitial lung disease with dermatomyositis and idiopathic interstitial pneumonia Source: International Congress 2017 – Lung function testing Year: 2017 Eosinophilic ratio in COPD and outcomes in pulmonary rehabilitation Source: International Congress 2018 – Pulmonary rehabilitation: exercise training, body composition, physical activity and other aspects Year: 2018 Blood monocyte counts as a potential prognostic marker for idiopathic pulmonary fibrosis: analysis from the Australian IPF registry Source: Eur Respir J, 55 (4) 1901855; 10.1183/13993003.01855-2019 Year: 2020 Serum KL-6 as a multidimensional biomarker in patients with idiopathic pulmonary fibrosis Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Neutrophil CD64 versus Neutrophil/Lymphocyte ratio (NLR) as markers predicting in-hospital outcome in acute exacerbation of COPD Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes Year: 2017 Correlations between specific radiological patterns and survival in idiopathic pulmonary fibrosis Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019